Literature DB >> 21715000

Arresting type 1 diabetes after diagnosis: GAD is not enough.

Chantal Mathieu1, Pieter Gillard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21715000     DOI： 10.1016/S0140-6736(11)60978-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Stem cell educator therapy and induction of immune balance.

Authors:  Yong Zhao
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

2.  Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.

Authors:  D Bobbala; X-L Chen; C Leblanc; M Mayhue; J Stankova; T Tanaka; Y-G Chen; S Ilangumaran; S Ramanathan
Journal:  Diabetologia       Date:  2012-08-14       Impact factor: 10.122

3.  Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.

Authors:  Yong Zhao; Zhaoshun Jiang; Tingbao Zhao; Mingliang Ye; Chengjin Hu; Zhaohui Yin; Heng Li; Ye Zhang; Yalin Diao; Yunxiang Li; Yingjian Chen; Xiaoming Sun; Mary Beth Fisk; Randal Skidgel; Mark Holterman; Bellur Prabhakar; Theodore Mazzone
Journal:  BMC Med       Date:  2012-01-10       Impact factor: 8.775

4.  Hair regrowth in alopecia areata patients following Stem Cell Educator therapy.

Authors:  Yanjia Li; Baoyong Yan; Hepeng Wang; Heng Li; Quanhai Li; Dong Zhao; Yana Chen; Ye Zhang; Wenxia Li; Jun Zhang; Shanfeng Wang; Jie Shen; Yunxiang Li; Edward Guindi; Yong Zhao
Journal:  BMC Med       Date:  2015-04-20       Impact factor: 8.775

5.  Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.

Authors:  Yong Zhao; Zhaoshun Jiang; Tingbao Zhao; Mingliang Ye; Chengjin Hu; Huimin Zhou; Zhaohui Yin; Yana Chen; Ye Zhang; Shanfeng Wang; Jie Shen; Hatim Thaker; Summit Jain; Yunxiang Li; Yalin Diao; Yingjian Chen; Xiaoming Sun; Mary Beth Fisk; Heng Li
Journal:  BMC Med       Date:  2013-07-09       Impact factor: 8.775

6.  Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Authors:  D Tatovic; M A McAteer; J Barry; A Barrientos; K Rodríguez Terradillos; I Perera; E Kochba; Y Levin; M Dul; S A Coulman; J C Birchall; C von Ruhland; A Howell; R Stenson; M Alhadj Ali; S D Luzio; G Dunseath; W Y Cheung; G Holland; K May; J R Ingram; M M U Chowdhury; F S Wong; R Casas; C Dayan; J Ludvigsson
Journal:  Immunother Adv       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.